T1	Participants 76 164	deceased-donor kidney transplant recipients at specified risk of delayed graft function:
T2	Participants 549 560	multicenter
T3	Participants 580 655	Deceased-donor kidney transplant patients at protocol-specified risk of DGF
T4	Participants 1338 1358	drug discontinuation
T5	Participants 1477 1497	early posttransplant
